138 related articles for article (PubMed ID: 23278234)
1. PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenaemia.
Paltoglou G; Tavernarakis G; Christopoulos P; Vlassi M; Gazouli M; Deligeoroglou E; Creatsas G; Mastorakos G
Clin Endocrinol (Oxf); 2013 Aug; 79(2):259-66. PubMed ID: 23278234
[TBL] [Abstract][Full Text] [Related]
2. [Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome].
Knebel B; Janssen OE; Hahn S; Nitzgen U; Jacob S; Haas J; Mack S; Müller-Wieland D; Kotzka J
Dtsch Med Wochenschr; 2009 May; 134(20):1040-6. PubMed ID: 19421925
[TBL] [Abstract][Full Text] [Related]
3. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
Demirci H; Yilmaz M; Ergun MA; Yurtcu E; Bukan N; Ayvaz G
Gynecol Endocrinol; 2010 May; 26(5):348-55. PubMed ID: 20388053
[TBL] [Abstract][Full Text] [Related]
4. The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.
San Millán JL; Alvarez-Blasco F; Luque-Ramírez M; Botella-Carretero JI; Escobar-Morreale HF
Hum Reprod; 2006 Dec; 21(12):3157-61. PubMed ID: 16880229
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
[TBL] [Abstract][Full Text] [Related]
6. PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome.
Dadachanji R; Shaikh N; Khavale S; Patil A; Shah N; Mukherjee S
Fertil Steril; 2015 Jul; 104(1):207-16. PubMed ID: 25956367
[TBL] [Abstract][Full Text] [Related]
7. PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women.
Dadachanji R; Shaikh N; Patil A; Shah N; Mukherjee S
Gene; 2018 Jun; 661():34-44. PubMed ID: 29604466
[TBL] [Abstract][Full Text] [Related]
8. Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case-control studies.
Liao D; Yu H; Han L; Zhong C; Ran X; Wang D; Mo L
J Endocrinol Invest; 2018 Nov; 41(11):1289-1300. PubMed ID: 29546656
[TBL] [Abstract][Full Text] [Related]
9. Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in southwest Chinese women.
Wang Y; Liu H; Fan P; Bai H; Zhang J; Zhang F
Eur J Endocrinol; 2012 May; 166(5):877-85. PubMed ID: 22301914
[TBL] [Abstract][Full Text] [Related]
10. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of Gly972Arg and C825T polymorphisms in Slovak women with polycystic ovary syndrome and their relation to the metabolic syndrome.
Dravecká I; Lazúrová I; Habalová V
Gynecol Endocrinol; 2010 May; 26(5):356-60. PubMed ID: 20170352
[TBL] [Abstract][Full Text] [Related]
12. [The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome].
Zhang F; Liu HW; Fan P; Bai H; Song Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):24-8. PubMed ID: 21355294
[TBL] [Abstract][Full Text] [Related]
13. The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome.
Lenarcik A; Bidzińska-Speichert B; Tworowska-Bardzińska U
Gynecol Endocrinol; 2010 Sep; 26(9):673-83. PubMed ID: 20334584
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome.
Wang K; You L; Shi Y; Wang L; Zhang M; Chen ZJ
Fertil Steril; 2008 Aug; 90(2):378-84. PubMed ID: 17953957
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of insulin action in polycystic ovary syndrome.
Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N
Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphism in insulin receptor gene exon 17 in women with polycystic ovary syndrome].
Jin L; Huang HF; Jin F; Qian YL
Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):323-6. PubMed ID: 15938783
[TBL] [Abstract][Full Text] [Related]
18. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia.
Cho LW; Kilpatrick ES; Jayagopal V; Diver MJ; Atkin SL
Clin Endocrinol (Oxf); 2008 Mar; 68(3):390-4. PubMed ID: 17888022
[TBL] [Abstract][Full Text] [Related]
19. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome.
Ferk P; Teran N; Gersak K
Hum Reprod; 2007 Apr; 22(4):1031-6. PubMed ID: 17189294
[TBL] [Abstract][Full Text] [Related]
20. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
